Clinical Trial Update: CSTC1 for Diabetic Foot Ulcers Phase II Study [Phase 2]

View source ↗

Summary

Phase II trial update for CSTC1 in diabetic foot ulcers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• CSTC1

Snippet

Sponsor: Charsire Biotechnology Corp. | Conditions: Diabetic Foot Ulcer, Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2022-04-12